Differential Expression of lncRNA CASC2 in the Serum of Childhood Asthma and Its Role in Airway Smooth Muscle Cells Proliferation and Migration
Yane Yang,Zhihong Sun,Tingting Ren,Wei Lei
DOI: https://doi.org/10.2147/JAA.S337236
2022-02-11
Journal of Asthma and Allergy
Abstract:Yane Yang, 1 Zhihong Sun, 1 Tingting Ren, 1 Wei Lei 2 1 Department of Pediatrics, The Second Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi, People's Republic of China; 2 Department of Pediatrics, Chang 'an District Hospital, Xi'an, Shaanxi, People's Republic of China Correspondence: Zhihong Sun, Department of Pediatrics, The Second Affiliated Hospital of Xi'an Medical University, 167 Fang Dong Street, Xi'an, 710038, People's Republic of China, Tel/Fax +86-2983553606, Email Purpose: Asthma is a common chronic disease in children. Abnormal expression of lncRNAs can be used as biomarkers for early diagnosis of asthma. The present study aimed to explore the expression change and clinical value of lncRNA CASC2 in asthma, and further investigate its potential mechanism. Patients and Methods: Seventy asthma children and 66 healthy controls were recruited. Levels of mRNAs were detected using qRT-PCR. Receiver operating characteristic (ROC) curves were drawn for diagnostic value evaluation. Asthma cell models were established using PDGF-BB in Human airway smooth muscle cells (ASMCs). Levels of Th1/Th2 related cytokines were detected using ELISA. Lipofectamine 3000 was used for cell transfection. The target relationship was verified using luciferase activity assay. Results: CASC2 was at a low level in asthma children in comparison with the healthy controls. Serum CASC2 can distinguish healthy individuals from asthma children. Overexpression of CASC2 inhibited PDGF-BB induced cell proliferation and migration. CASC2 upregulation inhibited the release of Th2 related cytokines (IL-4 and IL-10), but promoted the release of Th1-related cytokine (IFN-γ). In PDGF-BB treated ASMCs, the reduced expression of contractile phenotype marker (α-SMA) was detected, but the trend was reversed by CASC2 upregulation. LncRNA CASC2 serves as a ceRNA of miR-31-5p, overexpression of miR-31-5p reversed the influence of CASC2 on asthma in vitro. Conclusion: Serum CASC2 can distinguish healthy individuals from asthma children. CASC2 may be involved in childhood asthma through inhibiting ASMCs proliferation, migration and inflammation via sponging miR-31-5p. Keywords: asthma, lncRNA CASC2, miR-31-5p, ASMCs Asthma is a heterogeneous disease characterized by chronic airway inflammation and airway hyperresponsiveness. The clinical manifestations were heterogeneous and different degrees of airway inflammation and airway remodeling. 1 It is the most common chronic respiratory disease in childhood because it is inherited and often occurs in early childhood, with serious impacts on children's health. 2 Asthma is a chronic inflammatory disease of the airway that is co-acted by a variety of cells and their components, but its etiology is complex, and the specific pathogenesis is not fully understood. It has been reported that Airway remodeling starts early in childhood asthma. 3,4 Airway remodeling is a proposed mechanism that underlies the persistent loss of lung function associated with childhood asthma. 5 Airway smooth muscle cells (ASMCs) play an important role in airway remodeling. 6 Abnormal proliferation of ASMCs and airway inflammation has been identified as a hallmark of asthma, especially in fatal or severe asthma. 7 Hence, it is critical to explore the underlying mechanisms that regulate the proliferation and migration of ASMCs, inhibiting the changes of ASMCs may prevent the development of asthma. Current treatment methods cannot completely prevent airway remodeling and acute attacks. It is urgent to find more effective biomarkers to guide the diagnosis and treatment of asthma. Long non-coding RNAs (lncRNAs) are regulatory non-coding RNAs with a length of more than 200 nucleotides and no protein coding function. LncRNAs are involved in regulating the physiological processes of various cells. Currently, studies on lncRNAs have focused on the occurrence and development of tumors. 8 Recent findings proposed that lncRNAs serve as powerful regulators in immune response, and their expression profiles are different in patients with different types of asthma, suggesting that lncRNAs have a close relationship with the occurrence of asthma. 9,10 Recent studies have found that lncRNA CASC2 is not only involved in the formation of a variety of malignant tumors, but also can regulate the inflammatory response of the body. 11 CASC2 is low expressed in lipopolysaccharide-induced acute lung injury cell model and is involved in regulating the release of inflammatory factors. 11 CASC2 is poorly expressed in neonatal mice with bronchopulmonary dysplasia, and overexpression of CASC2 promotes the prol -Abstract Truncated-
immunology,allergy,respiratory system